Files

Download

Download Full Text (600 KB)

Description

Cancer Screening Research Network (CSRN) launched the Vanguard study to evaluate a new multicancer detection (MCD) screening tool in nine health systems nationwide. HFH Patient Engaged Research Center (PERC) advisors played a vital role by reviewing and providing input to ensure Vanguard’s processes and materials are accessible and culturally appropriate for the community. PERC advisors helped address patient concerns about multi-cancer detection tests.

Publication Date

11-12-2025

City

Detroit, MI

Enhancing Vanguard Research Study with Patient Engaged Research Advisors

Share

COinS